Mutagenesis of Gln294 of the reverse transcriptase of human immunodeficiency virus type-2 and its effects on the ribonuclease H activity

FEBS Letters

Volumn 582, Issue 18, 2008, Pages 2799-2805

  Bochner, R ^a   Duvshani, A ^a   Adir, N ^b   Hizi, A ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

HIV 1; HIV 2; Mutagenesis of Gln294; Reverse transcriptase; Ribonuclease H

Indexed keywords

PROTEIN P54; PROTEIN P56; RIBONUCLEASE H; RNA DIRECTED DNA POLYMERASE;

ARTICLE; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS 2; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; VIRUS MUTATION; WILD TYPE;

AMINO ACID SUBSTITUTION; DNA-DIRECTED DNA POLYMERASE; GLUTAMINE; HIV REVERSE TRANSCRIPTASE; HUMANS; MUTAGENESIS; PROTEIN CONFORMATION; RIBONUCLEASE H;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 47849087959     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.07.010     Document Type: Article

References (26)

1. Coffin J.M., Hughes S.H., and Varmus H.E. Retroviruses (1997), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
2. Skalka A.M., and Goff S.P. Reverse Transcriptase (1993), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
3. Jacobo Molina A., Ding J., Nanny R.G., Clark Jr. A.D., Lu X., Tantillo C., Williams R.L., Kamer G., Ferris A.L., Clark P., Hizi A., Hughes S.H., and Arnold E. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc. Natl. Acad. Sci. USA 90 (1993) 6320-6324
4. Sevilya Z., Loya S., Duvshani A., Adir N., and Hizi A. Mutagenesis of cysteine 280 of the reverse transcriptase of human immunodeficiency virus type-1: the effects on the ribonuclease H activity. J. Mol. Biol. 327 (2003) 19-30
5. Ren J., Bird L.E., Chamberlain P.P., Stewart-Jones G.B., Stuart D.I., and Stammers D.K. Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors. Proc. Natl. Acad. Sci. USA 99 (2002) 14410-14415
6. Kohlstaedt L.A., Wang J., Friedman J.M., Rice P.A., and Steitz T.A. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256 (1992) 1783-1790
7. Huang H., Chopra R., Verdine G.L., and Harrison S.C. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282 (1998) 1669-1675
8. Ollis D.L., Brick P., Hamlin R., Xuong N.G., and Steitz T.A. Structure of large fragment of Escherichia coli DNA polymerase I complexed with dTMP. Nature 313 (1985) 762-766
9. Pelletier H., Sawaya M.R., Kumar A., Wilson S.H., and Kraut J. Structures of ternary complexes of rat DNA polymerase beta, a DNA template-primer, and ddCTP. Science 264 (1994) 1891-1903
10. Hansen J.L., Long A.M., and Schultz S.C. Structure of the RNA-dependent RNA polymerase of poliovirus. Structure 5 (1997) 1109-1122
11. Jeruzalmi D., and Steitz T.A. Structure of T7 RNA polymerase complexed to the transcriptional inhibitor T7 lysozyme. EMBO J. 17 (1998) 4101-4113
12. Georgiadis M.M., Jessen S.M., Ogata C.M., Telesnitsky A., Goff S.P., and Hendrickson W.A. Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase. Structure 3 (1995) 879-892
13. Das D., and Georgiadis M.M. The crystal structure of the monomeric reverse transcriptase from Moloney murine leukemia virus. Structure 12 (2004) 819-829
14. Hizi A., Tal R., and Hughes S.H. Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli. Virology 180 (1991) 339-346
15. Hizi A., Tal R., Shaharabany M., and Loya S. Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2. J. Biol. Chem. 266 (1991) 6230-6239
16. Sevilya Z., Loya S., Adir N., and Hizi A. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit. Nucleic Acids Res. 31 (2003) 1481-1487
17. Sevilya Z., Loya S., Hughes S.H., and Hizi A. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits. J. Mol. Biol. 311 (2001) 957-971
18. Shaharabany M., and Hizi A. The catalytic functions of chimeric reverse transcriptases of human immunodeficiency viruses type 1 and type 2. J. Biol. Chem. 267 (1992) 3674-3678
19. Fan N., Rank K.B., Poppe S.M., Tarpley W.G., and Sharma S.K. Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase. Biochemistry 35 (1996) 1911-1917
20. Smith J.S., Gritsman K., and Roth M.J. Contributions of DNA polymerase subdomains to the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase. J. Virol. 68 (1994) 5721-5729
21. Hizi A., McGill C., and Hughes S.H. Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants. Proc. Natl. Acad. Sci. USA 85 (1988) 1218-1222
22. Sarafianos S.G., Das K., Tantillo C., Clark Jr. A.D., Ding J., Whitcomb J.M., Boyer P.L., Hughes S.H., and Arnold E. Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J. 20 (2001) 1449-1461
23. Das K., Lewi P.J., Hughes S.H., and Arnold E. Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors. Prog. Biophys. Mol. Biol. 88 (2005) 209-231
24. Nowotny M., Gaidamakov S.A., Ghirlando R., Cerritelli S.M., Crouch R.J., and Yang W. Structure of human RNase H1 complexed with an RNA/DNA hybrid: insight into HIV reverse transcription. Mol. Cell 28 (2007) 264-276
25. Law M.J., Chambers E.J., Katsamba P.S., Haworth I.S., and Laird-Offringa I.A. Kinetic analysis of the role of the tyrosine 13, phenylalanine 56 and glutamine 54 network in the U1A/U1 hairpin II interaction. Nucleic Acids Res. 33 (2005) 2917-2928
26. Hunter S.E., and Spremulli L.L. Mutagenesis of glutamine 290 in Escherichia coli and mitochondrial elongation factor Tu affects interactions with mitochondrial aminoacyl-tRNAs and GTPase activity. Biochemistry 43 (2004) 6917-6927